Drug may prevent development of invasive bladder cancer

A drug already approved for use in humans may prevent invasive bladder cancer, according to a study by researchers at the Stanford University School of Medicine . The researchers found that low doses of FK506, also known as tacrolimus, prevented the development of invasive bladder cancer in 10 out of 10 laboratory mice that were given a carcinogen over five months.

http://ift.tt/1qkgw8x